SI · SHOULDER INNOVATIONS, INC.

Summary

Shoulder Innovations announces full commercial launch of InSet I-135RFX Humeral Stem after successful limited release and expanded FDA clearance.

Key takeaways

• Full commercial launch of InSet I-135RFX Humeral Stem follows FDA clearance for fracture indications, expanding total shoulder arthroplasty use.
• Third addition to I-Series humeral stem line in three years, demonstrating ongoing product innovation.
• Product built on InSet lateral-lateral implant philosophy, shown to reduce complications and improve range of motion.
• CEO Rob Ball highlights milestone enabling support for full spectrum of shoulder arthroplasty procedures.